|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1993-2-24
|
|
pubmed:abstractText |
The mechanisms responsible for skin lesions during acute graft-vs.-host disease (aGVHD) after allogeneic bone marrow transplantation (BMT) are poorly understood. The exact role of various effector cell populations and "major" (particularly HLA-DP) or "minor" antigens as target molecules is not known. To investigate the nature of cells responsible for tissue injury, we cultured T cells from skin biopsy first with interleukin 2 (IL-2) alone and then in polyclonal activation conditions to avoid in vitro antigenic sensitization before specificity testing. We applied this method to two biopsies performed during aGVHD after semiallogeneic BMT and obtained cytotoxic T cells against four graft mismatches: CD8+ T cells against HLA-A2.2 and HLA-B27 and CD4+ T cells against HLA-DP101 and HLA-DP401. This demonstrates that T cells with documented specificity can be obtained from an aGVHD lesion without antigenic selection. Moreover, these data directly implicate DP as a potential target antigen for aGVHD.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-1371194,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-1693467,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-1700003,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-1706381,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-1710827,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-1871811,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-2137932,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-2297577,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-23008,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-2310832,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-2321019,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-2368152,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-2427602,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-2451691,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-2538410,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-2650045,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-2655222,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-2659108,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-2799919,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-2885638,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-2938743,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-2941488,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-3056281,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-3082048,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-3158700,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-3258650,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-3282358,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-3326216,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-3332157,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-3527302,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-3538541,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-3542078,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-3896348,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-6186923,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-6334238,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-6367851,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-6383061,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-6392220,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423212-7005277
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0021-9738
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
91
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
12-20
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:8423212-Humans,
pubmed-meshheading:8423212-Skin,
pubmed-meshheading:8423212-Female,
pubmed-meshheading:8423212-Male,
pubmed-meshheading:8423212-Bone Marrow Transplantation,
pubmed-meshheading:8423212-Adult,
pubmed-meshheading:8423212-Transplantation, Homologous,
pubmed-meshheading:8423212-Graft vs Host Disease,
pubmed-meshheading:8423212-Lymphocyte Activation,
pubmed-meshheading:8423212-Leukemia, Myeloid, Acute,
pubmed-meshheading:8423212-Histocompatibility Testing,
pubmed-meshheading:8423212-Leukemia, Myelogenous, Chronic, BCR-ABL Positive,
pubmed-meshheading:8423212-HLA-DR Antigens,
pubmed-meshheading:8423212-T-Lymphocytes,
pubmed-meshheading:8423212-T-Lymphocyte Subsets,
pubmed-meshheading:8423212-Antigens, CD,
pubmed-meshheading:8423212-HLA-A Antigens,
pubmed-meshheading:8423212-HLA-B Antigens,
pubmed-meshheading:8423212-HLA-DQ Antigens,
pubmed-meshheading:8423212-HLA-DP Antigens,
pubmed-meshheading:8423212-Blotting, Southern,
pubmed-meshheading:8423212-Gene Rearrangement, T-Lymphocyte
|
